Nigerian Sickle cell patients face N1 million a month bill as hospital admissions rises
Nigerians living with sickle cell disease face staggering healthcare costs
Nigerians living with sickle cell disease face staggering healthcare costs
U.S FDA has approved two groundbreaking gene therapies targeting sickle cell disease, marking a significant milestone in the realm of ...
A drug named Crizanlizumab, produced by Novartis has been approved for Sickle Cell treatment in England by the National Health ...